SYRINGE DRIVER MEDICATIONS

Size: px
Start display at page:

Download "SYRINGE DRIVER MEDICATIONS"

Transcription

1 SYRINGE DRIVER MEDICATIONS Christine Hull & Anita Webb Staff Nurses, Hospice in the Home 2015

2 Analgesics:- Groups of Medication used in Syringe Drivers Morphine sulphate Diamorphine Oxycodone Alfentanil

3 Anti-emetics Cyclizine Metoclopramide Haloperidol Levomepromazine

4 Sedation Midazolam Levomepromazine Haloperidol

5 Anti-secretory Hyoscine Butylbromide (Buscopan) Hyoscine Hydrobromide Glycopyrronium

6 Others Diclofenac Dexamethasone Ondansetron Octreotide

7 Diluents and Compatibility Drugs in syringe drivers are generally prepared with a diluent, commonly water for injection or Sodium Chloride 0.9% The diluent used should be compatible with the medicines to minimise site reactions and enable medicines to be given over a set period The appropriate diluent can contribute to symptom management and wellbeing of the patient

8 Watson et al (2011) Palliative Adult Network Guidelines 3rd Edition recommend water for injection as the diluent of choice with specific exceptions For example:- Sodium Chloride is the diluent of choice for Ketamine and Diclofenac

9 Drug Compatibility This is dependant on a number of factors which include:- Dose and strength of medicine Ph of each medicine and the final solution Diluting the mixture to the maximum volume may reduce both the risk of adverse site reactions and incompatibility The more drugs mixed together, the greater the risk of incompatibility

10 Troubleshooting If the solution in the syringe driver precipitates, crystallises or discolours, it may result from:- Solution being too warm Solution being over exposed to sunlight Too many medications added to the syringe Medications are not compatible Medication is past its expiry date Subcutaneous infusions should be monitored regularly to avoid the above Patient should be monitored regularly if symptom control is to be maintained

11 Transdermal patches If a patient is currently using a transdermal Buprenorphine or Fentanyl patch, treatment should continue when starting a syringe driver Breakthrough pain should be treated with equivalent breakthrough doses of s/c opioid For example, a Fentanyl patch of 25mcgs/hr requires a breakthrough of 5mgs of Diamorphine The total daily breakthrough medication is then given via the syringe driver in addition to the transdermal patch

12 Drug Conversions Oral Morphine to s/c Diamorphine divide 24hr dose by 3 For Example:- 180mg Oramorph in 24 hrs = 60mg s/c Diamorphine in 24 hrs Breakthrough dose is 1/6 th of 24hr dose, which is 10mg s/c Diamorphine

13 Drug Conversions cont. Oral Morphine to s/c Morphine divide 24 hr dose by 2 For example:- 60mg Oramorph = 30mg s/c Morphine Sulphate Breakthrough dose is 1/6 th of the 24hr dose, which is 5mg of s/c Morphine Sulphate

14 Drug Conversions cont. Oral Oxycodone to s/c Oxycodone divide the 24hr dose by 2 For example:- 20mg of oral Oxycodone = 10mg s/c Oxycodone

15 Drug Conversions cont. s/c Diamorphine to s/c Oxycodone For example:- 40mg of s/c Diamorphine = 120mg Oramorph 120mg of oral Oramorph = 60mg oral Oxycodone 60mg of oral Oxycodone = 30mg s/c Oxycodone

16 Converting m/r Morphine to Diamorphine For example:- Zomorph 30mg bd = Zomorph 60mg in 24 hrs Divide by 3 = 20mg s/c Diamorphine Breakthrough dose = 2.5 5mg s/c Diamorphine

17 Converting s/c Diamorphine to s/c Alfentanil Alfentanil is approximately 10 times as potent as Diamorphine For example:- 10mg s/c Diamorphine = 1mg s/c Alfentanil Breakthrough dose is 1/10 th of the 24hr dose which is 0.1mg s/c Alfentanil

Syringe driver in Palliative Care

Syringe driver in Palliative Care Syringe driver in Palliative Care Introduction: Syringe drivers are portable, battery operated devices widely used in palliative care to deliver medication as a continuous subcutaneous infusion over 24

More information

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO Anticipatory Medications for End of Life Patients oses must be proportional to the current analgesic medication Please refer ALL patients on Methadone or Ketamine to palliative care team for advice. Patients

More information

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,

More information

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL Doses of opiates must be proptional to current analgesic medication Please refer ALL patients on Methadone Ketamine to SPCT f advice. Patients

More information

Renal Palliative Care Last Days of Life

Renal Palliative Care Last Days of Life Renal Palliative Care Last Days of Life Introduction This guideline is an aid to clinical decision-making and good practice for patients with stage 4-5 chronic kidney disease (egfr

More information

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

PAIN MANAGEMENT Person established taking oral morphine or opioid naive. PAIN MANAGEMENT Person established taking oral morphine or opioid naive. Important; it is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member

More information

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

PAIN MANAGEMENT Patient established on oral morphine or opioid naive. PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member

More information

Algorithms for Symptom Management. In End of Life Care

Algorithms for Symptom Management. In End of Life Care Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the

More information

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of

More information

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In

More information

Isle of Wight Syringe Driver Compatibility Guidelines

Isle of Wight Syringe Driver Compatibility Guidelines Isle of Wight Syringe Driver Compatibility Guidelines Produced by The Earl Mountbatten Hospice, Isle of Wight Written January 2015, revision due January 2018 This guideline is available as a paper pocketbook

More information

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug COMMUNITY PRESCRIPTION CHART All entries should be in CAPITAL letters and in indelible black ink. If medications/ doses are stopped, cross through the relevant line clearly to avoid error. GP: PRESCRIBER

More information

Clatterbridge Centre for Oncology

Clatterbridge Centre for Oncology Clatterbridge Centre for Oncology CONTENTS 1. Why and when to use a syringe driver 2. Siting the syringe driver 3. Mixing and measuring 4. Setting up the syringe driver 5. Drug information 6. Common problems

More information

End of life prescribing guidance

End of life prescribing guidance End of life prescribing guidance Introduction This guidance has been prepared to ASSIST IN DECISION MAKING for the prescribing and monitoring of medicines useful in the management of symptoms commonly

More information

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30 If more information is required please seek help from specialist palliative care pioid dose conversion chart, syringe driver doses, rescue/prn doses and opioid patches Use the conversion chart to work

More information

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30) GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT These guidelines have been produced in collaboration with Dr Lucy Smyth, Consultant in Renal Medicine, Royal Devon and Exeter

More information

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation

More information

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary Doncaster & Bassetlaw Cancer Locality Palliative Core Formulary Approved by Doncaster & Bassetlaw Hospitals NHS Foundation Trust Drugs and Therapeutics Committee. DJ14/2155 Oct 2014 Review date: Oct 2017

More information

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number: FILE IN PATIENT S COMMUNITY HEALTH RECORD FOLDER : SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRERIPTION & ADMINISTRATION RECORD (SPAR) Abbreviations used in this document to be listed here with the full

More information

Supportive Care. End of Life Phase

Supportive Care. End of Life Phase Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of

More information

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be

More information

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE Reference: DCM029 Version: 1.1 This version issued: 07/06/18 Result of last review: Minor changes Date approved by owner (if applicable): N/A

More information

Care in the Last Days of Life

Care in the Last Days of Life Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient

More information

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117

More information

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure. Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients

More information

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] [Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] Patients with egfr greater than 30mL/min Patients with egfr less than 30mL/min Symptom Drug Dose Symptom Drug Dose

More information

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110 Berkshire Adult Palliative Care Guidelines - End of Life Care GL110 Approval Approval Group Job Title, Chair of Committee Date Drugs & Therapeutic Committee Chair, Drugs & Therapeutic Committee October

More information

End Stage Liver Disease Regional Audit Casenote Survey

End Stage Liver Disease Regional Audit Casenote Survey 1. This questionnaire is an audit of clinical documentation of patients who have died of end stage liver disease. If you have any questions about how this form should be completed please contact Dr Grace

More information

Using syringe pumps in palliative care

Using syringe pumps in palliative care Using syringe pumps in palliative care Facilitator: Barbara Stone RN Ground rules Medication matching game Learning outcomes To identify the indications for using a syringe pump To discuss the general

More information

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1 TRUST WIDE/DIVISIONAL DOCUMENT Delete as appropriate Policy/Standard Operating Procedure/ Clinical Guideline DOCUMENT TITLE: Policy and Procedure for the T34 Ambulatory Syringe Pump in adults (Palliative

More information

Syringe Drivers. Back to top

Syringe Drivers. Back to top Page 1 of 8 Syringe Drivers Introduction Indications for use Advantages Method Siting syringe driver Boost facility Transfer to hospital/hospice syringe driver drugs Drug compatibility P.r.n medication

More information

Palliative care for heart failure patients. Susan Addie

Palliative care for heart failure patients. Susan Addie Palliative care for heart failure patients Susan Addie Treatments The most common limiting and distressing complaint is of fatigue and breathlessness. Optimal treatment strategies relieve symptoms, improves

More information

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice. Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative

More information

Alternative Routes of Drug Administration (analgesia) Dr Andrew Dickman Consultant Pharmacist

Alternative Routes of Drug Administration (analgesia) Dr Andrew Dickman Consultant Pharmacist Alternative Routes of Drug Administration (analgesia) Dr Andrew Dickman Consultant Pharmacist Alternative Routes of Drug Administration Introduction Subcutaneous Route Contemporary Issues Compatibility

More information

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice Essential Syringe Driver Training for T 34 Elaine Bird St Luke s Hospice Aim For all practitioners to be accountable for their individual competence and capability when caring for a resident with a T34

More information

Conservative Management of Uraemia

Conservative Management of Uraemia Conservative Management of Uraemia Information for Health Professionals Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact: The Renal Specialist

More information

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE EAST LANCASHIRE SPECIALIST PALLIATIVE CARE TEAM EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Reviewed and updated August 2009 Next review date August 2011 Approved

More information

Care of dying adults in the last days of life. Improving care at the very end of life.

Care of dying adults in the last days of life. Improving care at the very end of life. Care of dying adults in the last days of life Improving care at the very end of life. Foreword We will all experience death, whether it is our own or that of a loved one. The bereaved person s perception

More information

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett Anticipatory prescribing and end of life considerations Dr Stephanie Lippett contents Pain Restlessness/agitation Nausea/vomiting Secretions Syringe driver Anticipatory prescribing Important things to

More information

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Originally produced: July 2006 First Review: August 2009 Second Review: November 2011 For review November 2013 Approved

More information

This survey aims to look at individual practice and can be completed by any healthcare professional.

This survey aims to look at individual practice and can be completed by any healthcare professional. This survey aims to look at individual practice and can be completed by any healthcare professional. If you have any questions about how this form should be completed please contact Dr Grace Ting (ghlting@doctors.net.uk)

More information

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage

More information

Symptom Management Guidelines for End of Life Care

Symptom Management Guidelines for End of Life Care Symptom Management Guidelines for End of Life Care The following pages are guidelines for the management of common symptoms in the last few days of life. General principles: 1. Consider how symptoms can

More information

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure Care of the Dying Management in Severe Renal Failure Clinical Guideline Early recognition of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance

More information

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure Care of the Dying Management in Severe Renal Failure Clinical Guideline Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance

More information

Palliative Prescribing - Pain

Palliative Prescribing - Pain Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing

More information

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven Bradford, Airedale, Wharfedale & Craven Managed Clinical Network SYMPTOM CONTROL IN THE LAST DAYS OF LIFE Guidelines for Healthcare Professionals Bradford, Airedale, Wharfedale & Craven Signs and symptoms

More information

Access to Palliative Care Drugs and Advice through Lothian Primary Care NHS Trust Community Pharmacy Palliative Care Network

Access to Palliative Care Drugs and Advice through Lothian Primary Care NHS Trust Community Pharmacy Palliative Care Network Access to Palliative Care Drugs and Advice through Lothian Primary Care NHS Trust Community Pharmacy Palliative Care Network Information for GPs, community pharmacists and district nurses First issued

More information

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti- Page 1 of 8 Analgesia The World Health Organisation (WHO, 1990) has devised a model to assist health care professionals in the management of cancer pain. The recommendations include managing pain, by the

More information

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients. We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients. The closing date for responses is 19th December The results

More information

Lothian Palliative Care Guidelines POCKET EDITION 2004

Lothian Palliative Care Guidelines POCKET EDITION 2004 Lothian Palliative Care Guidelines POCKET EDITION 2004 These guidelines have been developed by a multidisciplinary group of specialist and non-specialist health professionals from hospital, community and

More information

Eastern Health and Social Services Board Palliative Care

Eastern Health and Social Services Board Palliative Care Eastern Health and Social Services Board Palliative Care Out of Hours Symptom advice leaflets Adult Palliative care patients (Compiled by Macmillan GP Facilitators March 2008) 1 CONTENTS PAIN Control of

More information

What s New 2003? What new treatments? What have you discontinued? More information please!

What s New 2003? What new treatments? What have you discontinued? More information please! What s New 2003? What new treatments? What have you discontinued? More information please! 1 What s New 2003? Submissions = 137 UK = 52 (38%) Doctors = 60% Nurses = 25% Pharmacists = 15% 2 What s New?

More information

Planning for the future; A guide to symptom control at end of life in advanced dementia

Planning for the future; A guide to symptom control at end of life in advanced dementia Planning for the future; A guide to symptom control at end of life in advanced dementia Item Type Guideline Authors Irish Hospice Foundation;St Vincent's Hospital, Athy;St Brigid's Hospice Publisher Irish

More information

Coversheet for Network Site Specific Group Agreed Documentation

Coversheet for Network Site Specific Group Agreed Documentation Coversheet for Network Site Specific Group Agreed Documentation This sheet is to accompany all documentation agreed by Pan Birmingham Cancer Network Site Specific Groups. This will assist the Network Governance

More information

BACKGROUND Measuring renal function :

BACKGROUND Measuring renal function : A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

More information

Palliative Care Formulary

Palliative Care Formulary Palliative Care Formulary 2016-2019 This formulary for pain and symptom management in adults is intended as a guide for prescribers in hospital and community. Special care should be taken when prescribing

More information

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents:

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents: Palliative Care Out-of-hours. A resource pack for West Dorset Contents: Section 1 Supply of drugs DCH Pharmacy hours and arrangements How to contact a community pharmacist out of hours Palliative care

More information

Palliative Care Impact Survey

Palliative Care Impact Survey September 2018 Contents Introduction...3 Headlines...3 Approach...4 Findings...4 Which guideline are used...4 How and where the guidelines are used...6 Alternative sources of information...7 Use of the

More information

tablet/capsule Paracetamol 500mg

tablet/capsule Paracetamol 500mg Formulary Item Restrictions and/or Advice Non-opioid analgesics + compound analgesic preparations Aspirin 75mg dispersible Aspirin 300mg dispersible Aspirin 300mg Aspirin 75mg EC Paracetamol 500mg / Paracetamol

More information

Palliative Care. Pocketbook 4

Palliative Care. Pocketbook 4 Nottinghamshire STP EOL Programme Board 2019 Review 2022 Palliative Care Pocketbook 4 Contents Pain Guidelines page 2 Nausea and Vomiting page 9 Inoperable Bowel Obstruction page 10 Constipation page 11

More information

MND Just in Case kit Information for GPs

MND Just in Case kit Information for GPs MND Just in Case kit Information for GPs What is the MND Just in Case kit? 2 Motor neurone disease (MND) is a progressive and terminal disease that results in degeneration of the motor neurones in the

More information

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist Respiratory Secretions Care in the last 72 hours of life Paul Tait, pharmacist 50% Why? Inability to swallow & clear secretions Ineffective cough Reduced consciousness Pooling of secretions in the throat

More information

McKinley T34 Syringe Pump Policy and Procedure

McKinley T34 Syringe Pump Policy and Procedure McKinley T34 Syringe Pump Policy and Procedure Author(s) & Designation Lead Clinician if appropriate In consultation with Practice Education Facilitator, Syringe Driver Training Lead Pharmacist Community

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES SCHEDULE 2 THE SERVICES A. Service Specifications Mandatory headings 1 4: mandatory but detail for local determination and agreement Optional headings 5-7: optional to use, detail for local determination

More information

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine End of Life Care Dr Anne Garry Consultant in Palliative Medicine Concerns voiced both by public and professionals.. Implementation and on-going training highly variable across country Decisions made by

More information

POLICY / PROCEDURE FOR THE USE OF THE McKinley T34 SYRINGE DRIVER

POLICY / PROCEDURE FOR THE USE OF THE McKinley T34 SYRINGE DRIVER POLICY / PROCEDURE FOR THE USE OF THE McKinley T34 SYRINGE DRIVER This is a working document and any changes that become necessary to this policy must be notified in writing to the Macmillan Pharmacist

More information

Guidelines for Syringe Driver Management in Palliative Care in New Zealand

Guidelines for Syringe Driver Management in Palliative Care in New Zealand Guidelines for Syringe Driver Management in Palliative Care in New Zealand i Citation: Ministry of Health. 2009. Guidelines for Syringe Driver Management in Palliative Care in New Zealand. Wellington:

More information

East Kent Prescribing Group

East Kent Prescribing Group East Kent Prescribing Group Symptom Control and Care of the Dying Patient: Palliative Care Guidelines 5th Edition Approved by the East Kent Prescribing Group. Approved by: East Kent Prescribing Group (Representing

More information

DRUG COMBINATIONS IN PALLIATIVE CARE: A COMPATIBILITY STUDY

DRUG COMBINATIONS IN PALLIATIVE CARE: A COMPATIBILITY STUDY DRUG COMBINATIONS IN PALLIATIVE CARE: A COMPATIBILITY STUDY HEATHER LOUISE KEAN A thesis submitted in partial fulfilment of the requirements of Liverpool John Moores University for the degree of Master

More information

PRIMARY CARE PALLIATIVE CARE FORMULARY

PRIMARY CARE PALLIATIVE CARE FORMULARY PRIMARY CARE PALLIATIVE CARE FORMULARY National Institute for Health and Care Excellence (NICE) guidance NG31 (Care of dying adults in the last days of life) supports the need to prescribe anticipatory

More information

Palliative Care. Guidelines for prescribing analgesic in palliative care THREE PRESCRIBING IN PALLIATIVE CARE GUIDELINES FOR MANAGING COMMON SYMPTOMS

Palliative Care. Guidelines for prescribing analgesic in palliative care THREE PRESCRIBING IN PALLIATIVE CARE GUIDELINES FOR MANAGING COMMON SYMPTOMS PRESCRIBING IN PALLIATIVE CARE VERSION 1.1: NOVEMBER 2003 DATE OF REVIEW: JULY 2005 Palliative Care THREE Guidelines for prescribing analgesic in palliative care GUIDELINES FOR MANAGING COMMON SYMPTOMS

More information

Syringe drivers. *precipitation may be seen at higher doses

Syringe drivers. *precipitation may be seen at higher doses Syringe drivers A syringe driver should be considered in the palliative care setting when a patient is unable to take oral medication due to nausea, dysphagia, intestinal obstruction, weakness or coma.

More information

AMBER Prescribing should only be undertaken in General Practice under the advice of the local hospice or specialist palliative care team.

AMBER Prescribing should only be undertaken in General Practice under the advice of the local hospice or specialist palliative care team. PRIMARY CARE PALLIATIVE CARE FORMULARY This formulary has been developed between West Essex CCG and the palliative care team at St Clare Hospice. The aim of the formulary is to ensure that medicines use

More information

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon Symptom Control in the Community Setting Dr Andrew Tysoe-Calnon Lead Consultant t Common symptoms Pain Agitation Shortness of breath Nausea and vomiting Intestinal obstruction Confusion Pain Occurs in

More information

Prescribing Examples: Basics

Prescribing Examples: Basics Prescribing Examples: Basics 7 0 Pregabolin 5 50mg 05.. 5 6 7 8 9 5 6 5 5 5 5 50 50 50 50 75 75 RF RF RF RF RF RF 5 5 5 5 50 50 50 PJ TF PJ PJ TF TF TF 50 75 75 75 75 TF A: REGULAR PRERIPTION SHEET 5 6

More information

Symptom Management in the last weeks & days of life. Facilitator: Vernon Davis RN/Community Team Leader Rowcroft Community Team

Symptom Management in the last weeks & days of life. Facilitator: Vernon Davis RN/Community Team Leader Rowcroft Community Team Symptom Management in the last weeks & days of life Facilitator: Vernon Davis RN/Community Team Leader Rowcroft Community Team Session objectives To identify common symptoms at the end of life To increase

More information

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.

More information

Yorkshire Cancer Network

Yorkshire Cancer Network Yorkshire Cancer Network and Humber & Yorkshire Coast Cancer Network A GUIDE TO SYMPTOM MANAGEMENT IN PALLIATIVE CARE Publication date: June 2009 Review date: May 2011 YORKSHIRE CANCER NETWORK PALLIATIVE

More information

West Midlands Palliative Care Physicians. Palliative care. Guidelines for the use of drugs in symptom control

West Midlands Palliative Care Physicians. Palliative care. Guidelines for the use of drugs in symptom control West Midlands Palliative Care Physicians Palliative care Guidelines for the use of drugs in symptom control Revised Jan 2012 1 5th Edition, 2012 Guidelines for the use of drugs in symptom control These

More information

BJF Acute Pain Team Formulary Group

BJF Acute Pain Team Formulary Group Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution

More information

Palliative Patient in Emergency Department

Palliative Patient in Emergency Department Palliative Patient in Emergency Department Dr Thiru Thirukkumaran Palliative Care Services NW THO Northwest Regional Hospital, Burnie Northwest Tasmania Outline the Session Introduction What is palliative

More information

ADULT SYRINGE DRIVER PROTOCOL (T34)

ADULT SYRINGE DRIVER PROTOCOL (T34) ADULT SYRINGE DRIVER PROTOCOL (T34) Version Date Purpose of Issue/Description of Change Review Date 3 May 2016 Guidelines for T34 syringe driver May 2018 Status Publication Scheme FOI Classification Function/Activity

More information

Administration and Supply of Emergency Medicines

Administration and Supply of Emergency Medicines APPENDIX WHO CAN GIVE WHAT? Administration and Supply of Emergency Clinician Authorisation Key to Exemptions from legislation: NPP Non Parenteral POM. Can be given according to a protocol. 7 HMR 0, Schedule

More information

CCR-BPD020 BERKSHIRE ADULT PALLIATIVE CARE GUIDELINES. SECTION 3: End of Life Symptom Control. Berkshire Healthcare NHS Foundation Trust

CCR-BPD020 BERKSHIRE ADULT PALLIATIVE CARE GUIDELINES. SECTION 3: End of Life Symptom Control. Berkshire Healthcare NHS Foundation Trust CCR-BPD020 BERKSHIRE ADULT PALLIATIVE CARE GUIDELINES SECTION 3: End of Life Symptom Control Berkshire Healthcare NHS Foundation Trust Did you print this document yourself? Please be advised that the Trust

More information

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Policy Number : DC020 Issue Date: October 2014 Review date: October 2016 Policy Owner: Head Community Services Monitor:

More information

PRIMARY CARE PALLIATIVE CARE FORMULARY

PRIMARY CARE PALLIATIVE CARE FORMULARY PRIMARY CARE PALLIATIVE CARE FORMULARY This formulary has been developed between West Essex CCG and the palliative care team at St Clare Hospice. The aim of the formulary is to ensure that medicines use

More information

Administration of Drugs via the CME Medical T34 Syringe Driver Standard Operating Procedure

Administration of Drugs via the CME Medical T34 Syringe Driver Standard Operating Procedure Administration of Drugs via the CME Medical T34 Syringe Driver Standard Operating Procedure DOCUMENT CONTROL: Version: 3 Ratified by: Quality and Safety Sub Committee Date ratified: 30 May 2017 Name of

More information

GUIDELINES FOR CONVERSION FROM A STRONG OPIOID TO METHADONE

GUIDELINES FOR CONVERSION FROM A STRONG OPIOID TO METHADONE GUIDELINES FOR CONVERSION FROM A STRONG OPIOID TO METHADONE GENERAL PRINCIPLES Methadone may be used as a strong opioid alternative when severe cancer-related pain responds poorly to other opioids, or

More information

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK GUIDELINES AND AUDIT IMPLEMENTATION NETWORK General Palliative Care Guidelines The Management of Pain at the End Of Life November 2010 Aim To provide a user friendly, evidence based guide for the management

More information

Implementing the recommendation on medication management and symptom control

Implementing the recommendation on medication management and symptom control Implementing the recommendation on medication management and symptom control Mike Grocott Professor of Anaesthesia and Critical Care Medicine University of Southampton Consultant in Critical Care Medicine

More information

ESSEX PALLIATIVE, SUPPORTIVE AND END OF LIFE CARE GROUP FORMULARY AND GUIDELINES FOR MANAGEMENT

ESSEX PALLIATIVE, SUPPORTIVE AND END OF LIFE CARE GROUP FORMULARY AND GUIDELINES FOR MANAGEMENT ESSEX PALLIATIVE, SUPPORTIVE AND END OF LIFE CARE GROUP FORMULARY AND GUIDELINES FOR MANAGEMENT Updated December 2017 1 CONTENTS Page number Introduction and local contacts p. 3 General Principles Principles

More information

General Palliative Care Guidelines for the Management of Pain at the End of Life in Adult Patients

General Palliative Care Guidelines for the Management of Pain at the End of Life in Adult Patients General Palliative Care Guidelines for the Management of Pain at the End of Life in Adult Patients February 2011 Contents Introduction 3 Understanding Pain 5 Principles of Pain Management 8 Assessment

More information

Ketamine and Methadone Supra- Regional Audit Presentation

Ketamine and Methadone Supra- Regional Audit Presentation Ketamine and Methadone Supra- Regional Audit Presentation Audit Group: Alison Coackley, Anthony Thompson, Graham Whyte, Helen Bonwick, Ruth Clark, Agnes Noble, Aileen Scott, Andrew Dickman, Sarah Fradsham

More information

Syringe Pumps: Guidance for the use with babies, children and young people in the community setting within Worcestershire

Syringe Pumps: Guidance for the use with babies, children and young people in the community setting within Worcestershire Syringe Pumps: Guidance for the use with babies, children and young people in the community setting within Worcestershire Syringe Pumps: Guidance for the use with babies, children and young people in the

More information

If dialysis is not started, established renal failure will eventually lead to death although the time scale is variable from weeks to months.

If dialysis is not started, established renal failure will eventually lead to death although the time scale is variable from weeks to months. Supportive care for adult renal patients with Established Renal Failure : information for GPs and District Nurses RRCV CMG Nephrology Service 1. Introduction 1.1 Supportive care for renal patients Part

More information

The John Walls Renal Unit Leicester General Hospital University Hospitals of Leicester

The John Walls Renal Unit Leicester General Hospital University Hospitals of Leicester The John Walls Renal Unit Leicester General Hospital University Hospitals of Leicester Supportive Care for Renal Patients Author: Renal and Palliative Care Written May 2010; updated May 2012 and Dec 2012

More information

PALLIATIVE CARE PRESCRIBING

PALLIATIVE CARE PRESCRIBING PALLIATIVE CARE PRESCRIBING LANCASHIRE AND SOUTH CUMBRIA SPECIALIST PALLIATIVE CARE SERVICES 2010 Refer to electronic verson site for latest information. Review Date September 2011 NAVIGATIONAL INSTRUCTIONS

More information

What else is new (other symptoms) DR ANDREW DAVIES

What else is new (other symptoms) DR ANDREW DAVIES What else is new (other symptoms) DR ANDREW DAVIES Outline Nausea & vomiting Petroleum jelly (and oxygen) Nausea & vomiting MASCC / ESMO recommendations MASCC / ESMO recommendations General: The anti-emetic

More information